Cryoviva Biotech Profile
Key Indicators
- Authorised Capital ₹ 20.00 Cr
as on 24-10-2024
- Paid Up Capital ₹ 20.00 Cr
as on 24-10-2024
- Company Age 19 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 69.00 Cr
as on 24-10-2024
- Revenue 1.27%
(FY 2023)
- Profit 16.72%
(FY 2023)
- Ebitda 11.63%
(FY 2023)
- Net Worth 17.69%
(FY 2023)
- Total Assets -81.05%
(FY 2023)
About Cryoviva Biotech
The Corporate was formerly known as Cryobanks International India Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 20.00 Cr and a paid-up capital of Rs 20.00 Cr.
The company has closed loans amounting to ₹69.00 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Cryoviva Biotech Private Limited India are Manish Agarwal as CFO and Vivek Singh as Company Secretary. Raj Gandhi, Rajesh Chopra, Satyanarayan Sharma, and Two other members serve as directors at the Company.
- CIN/LLPIN
U85195DL2005PTC137768
- Company No.
137768
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Jun 2005
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Cryoviva Biotech?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vivek Singh  | Company Secretary | 14-Nov-2019 | Current |
| Manish Agarwal | CFO | 27-Sep-2021 | Current |
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Raj Gandhi | Director | 24-Aug-2011 | Current |
| Rajesh Chopra | Director | 14-Jun-2022 | Current |
| Satyanarayan Sharma | Director | 31-May-2021 | Current |
| Satya Singh | Director | 14-Jun-2022 | Current |
| Upamannyue Roychoudhury | Whole-Time Director | 30-Apr-2022 | Current |
Financial Performance and Corporate Structure Insights of Cryoviva Biotech.
Cryoviva Biotech Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 1.27% increase. The company also saw a substantial improvement in profitability, with a 16.72% increase in profit. The company's net worth Soared by an impressive increase of 17.69%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cryoviva Biotech?
In 2022, Cryoviva Biotech had a promoter holding of 87.50% and a public holding of 12.50%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Alisha Torrent Closures (India) Private LimitedActive 13 years 2 monthsRaj Gandhi is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Yes Bank Limited Creation Date: 20 Mar 2017 | ₹15.00 Cr | Satisfied |
Yes Bank Limited Creation Date: 25 Mar 2014 | ₹10.00 Cr | Satisfied |
Yes Bank Limited Creation Date: 25 Mar 2014 | ₹30.00 Cr | Satisfied |
How Many Employees Work at Cryoviva Biotech?
Cryoviva Biotech has a workforce of 182 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cryoviva Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cryoviva Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
